These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 28410293)

  • 1. Long-term Efficacy of Methotrexate Plus Vinblastine/Vinorelbine in a Large Series of Patients Affected by Desmoid-Type Fibromatosis.
    Palassini E; Frezza AM; Mariani L; Lalli L; Colombo C; Fiore M; Messina A; Casale A; Morosi C; Collini P; Stacchiotti S; Casali PG; Gronchi A
    Cancer J; 2017; 23(2):86-91. PubMed ID: 28410293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Low-dose methotrexate combined with vinorelbine for inoperable desmoid tumor: efficacy and the prognostic factors].
    Fan Z; Li S; Fang Z; Liu J; Bai C; Xue R; Zhang L; Gao T
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jan; 36(1):39-43. PubMed ID: 26806736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of desmoid tumors and fibromatosis using vinorelbine.
    Weiss AJ; Horowitz S; Lackman RD
    Am J Clin Oncol; 1999 Apr; 22(2):193-5. PubMed ID: 10199460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical benefit of methotrexate plus vinorelbine chemotherapy for desmoid fibromatosis (DF) and correlation of treatment response with MRI.
    Ingley KM; Burtenshaw SM; Theobalds NC; White LM; Blackstein ME; Gladdy RA; Thipphavong S; Gupta AA
    Cancer Med; 2019 Sep; 8(11):5047-5057. PubMed ID: 31301110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral vinorelbine in young patients with desmoid-type fibromatosis.
    Kornreich L; Orbach D; Nicolas N; Brisse HJ; Berlanga P; Defachelles AS; Mansuy L; Verite C; Saumet L; Karanian M; Corradini N
    Tumori; 2023 Oct; 109(5):511-518. PubMed ID: 37114926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging patterns of tumor response to chemotherapy in desmoid-type fibromatosis.
    Zanchetta E; Ciniselli CM; Bardelli A; Colombo C; Stacchiotti S; Baldi GG; Provenzano S; Bertulli R; Bini F; Casale A; Greco FG; Ferrari A; Verderio P; Fiore M; Gronchi A; Casali PG; Morosi C; Palassini E
    Cancer Med; 2021 Jul; 10(13):4356-4365. PubMed ID: 34102009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study.
    Toulmonde M; Pulido M; Ray-Coquard I; Andre T; Isambert N; Chevreau C; Penel N; Bompas E; Saada E; Bertucci F; Lebbe C; Le Cesne A; Soulie P; Piperno-Neumann S; Sweet S; Cecchi F; Hembrough T; Bellera C; Kind M; Crombe A; Lucchesi C; Le Loarer F; Blay JY; Italiano A
    Lancet Oncol; 2019 Sep; 20(9):1263-1272. PubMed ID: 31331699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemotherapy using vinblastine and methotrexate for the treatment of progressive desmoid tumor in children.
    Skapek SX; Hawk BJ; Hoffer FA; Dahl GV; Granowetter L; Gebhardt MC; Ferguson WS; Grier HE
    J Clin Oncol; 1998 Sep; 16(9):3021-7. PubMed ID: 9738571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desmoid with biweekly methotrexate and vinblastine shows similar effects to weekly administration: A phase II clinical trial.
    Nishida Y; Hamada S; Urakawa H; Ikuta K; Sakai T; Koike H; Ito K; Emoto R; Ando Y; Matsui S
    Cancer Sci; 2020 Nov; 111(11):4187-4194. PubMed ID: 32816351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of low-dose chemotherapy with methotrexate and vinblastine for patients with extra-abdominal desmoid-type fibromatosis: a systematic review.
    Shimizu K; Hamada S; Sakai T; Koike H; Yoshida M; Nishida Y
    Jpn J Clin Oncol; 2020 Apr; 50(4):419-424. PubMed ID: 31845730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group Phase II Trial.
    Skapek SX; Ferguson WS; Granowetter L; Devidas M; Perez-Atayde AR; Dehner LP; Hoffer FA; Speights R; Gebhardt MC; Dahl GV; Grier HE;
    J Clin Oncol; 2007 Feb; 25(5):501-6. PubMed ID: 17290057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced aggressive fibromatosis: Effective palliation with chemotherapy.
    Constantinidou A; Jones RL; Scurr M; Al-Muderis O; Judson I
    Acta Oncol; 2011 Apr; 50(3):455-61. PubMed ID: 20799916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis.
    Azzarelli A; Gronchi A; Bertulli R; Tesoro JD; Baratti D; Pennacchioli E; Dileo P; Rasponi A; Ferrari A; Pilotti S; Casali PG
    Cancer; 2001 Sep; 92(5):1259-64. PubMed ID: 11571741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial adenomatosis polyposis-related desmoid tumours treated with low-dose chemotherapy: results from an international, multi-institutional, retrospective analysis.
    Napolitano A; Provenzano S; Colombo C; Vitellaro M; Brunello A; Badalamenti G; Nannini M; Ibrahim T; Hohenberger P; Gasperoni S; Gennatas S; Jones RL; Hindi N; Martin-Broto J; Spalato Ceruso M; Silletta M; Dei Tos AP; Gronchi A; Stacchiotti S; Santini D; Tonini G; Palassini E; Vincenzi B
    ESMO Open; 2020 Jan; 5(1):. PubMed ID: 31958289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination chemotherapy in adult desmoid tumors.
    Patel SR; Evans HL; Benjamin RS
    Cancer; 1993 Dec; 72(11):3244-7. PubMed ID: 8242548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination chemotherapy with methotrexate and vinblastine for surgically unresectable, aggressive fibromatosis.
    Park KH; Choi YJ; Kim KW; Ro KH; Kang CH; Song SH; Park JH
    Jpn J Clin Oncol; 2016 Sep; 46(9):845-9. PubMed ID: 27365524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggressive fibromatosis in children and adolescents: the Italian experience.
    Meazza C; Bisogno G; Gronchi A; Fiore M; Cecchetto G; Alaggio R; Milano GM; Casanova M; Carli M; Ferrari A
    Cancer; 2010 Jan; 116(1):233-40. PubMed ID: 19950127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective treatment of multifocal aggressive fibromatosis with low-dose chemotherapy.
    Caglar K; Ozyönüm H; Akalin M; Balci S
    Turk J Pediatr; 2006; 48(4):365-8. PubMed ID: 17290575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose chemotherapy with vinblastine and methotrexate in childhood desmoid tumors.
    Reich S; Overberg-Schmidt US; Bührer C; Henze G
    J Clin Oncol; 1999 Mar; 17(3):1086. PubMed ID: 10071306
    [No Abstract]   [Full Text] [Related]  

  • 20. Low-dose chemotherapy with methotrexate and vinblastine for patients with desmoid tumors: relationship to CTNNB1 mutation status.
    Nishida Y; Tsukushi S; Urakawa H; Hamada S; Kozawa E; Ikuta K; Ando Y; Ishiguro N
    Int J Clin Oncol; 2015 Dec; 20(6):1211-7. PubMed ID: 25899770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.